Development
Ultralife Corporation
ULBI
$7.70
-$0.155-1.98%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 39.49M | 42.69M | 31.92M | 36.11M | 33.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.49M | 42.69M | 31.92M | 36.11M | 33.23M |
| Cost of Revenue | 29.71M | 32.10M | 24.48M | 28.03M | 26.52M |
| Gross Profit | 9.77M | 10.59M | 7.44M | 8.08M | 6.72M |
| SG&A Expenses | 5.77M | 5.15M | 5.38M | 5.43M | 5.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.35M | 39.03M | 31.89M | 35.11M | 33.82M |
| Operating Income | 2.14M | 3.67M | 26.00K | 996.00K | -586.00K |
| Income Before Tax | 1.75M | 4.72M | -468.00K | -380.00K | -332.00K |
| Income Tax Expenses | 446.00K | 1.38M | -133.00K | -155.00K | -90.00K |
| Earnings from Continuing Operations | 1.30M | 3.35M | -335.00K | -225.00K | -242.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 27.00K | -8.00K | -11.00K | 1.00K | 3.00K |
| Net Income | 1.33M | 3.34M | -346.00K | -224.00K | -239.00K |
| EBIT | 2.14M | 3.67M | 26.00K | 996.00K | -586.00K |
| EBITDA | 3.12M | 4.65M | 997.00K | 2.04M | 547.00K |
| EPS Basic | 0.08 | 0.21 | -0.02 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.07 | 0.18 | -0.02 | 0.02 | -0.01 |
| EPS Diluted | 0.08 | 0.21 | -0.02 | -0.02 | -0.01 |
| Normalized Diluted EPS | 0.07 | 0.18 | -0.02 | 0.02 | -0.01 |
| Average Basic Shares Outstanding | 16.24M | 16.14M | 16.14M | 16.14M | 16.13M |
| Average Diluted Shares Outstanding | 16.30M | 16.14M | 16.14M | 16.14M | 16.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |